Table 2.
Post-transplant outcomes according to the clusters.
Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | Cluster 5 | Cluster 6 | |
---|---|---|---|---|---|---|
Primary non-function | 36 (1.8%) | 26 (1.2%) | 5 (1.4%) | 4 (1.2%) | 7 (0.7%) | 31 (1.0%) |
Delayed graft function | 759 (38.3%) | 535 (25.1%) | 149 (41.7%) | 101 (30.2%) | 340 (31.8%) | 1247 (40.8%) |
1-year survival | 95.3% | 93.9% | 91.0% | 98.1% | 92.2% | 92.5% |
5-year survival | 79.2% | 68.6% | 62.1% | 90.5% | 68.9% | 67.0% |
1-year death-censored graft survival | 91.2% | 94.3% | 87.8% | 85.6% | 93.4% | 92.3% |
5-year death-censored graft survival | 73.1% | 84.3% | 70.1% | 81.8% | 80.5% | 76.2% |
1-year graft survival | 88.1% | 90.2% | 81.8% | 84.8% | 88.6% | 87.3% |
5-year graft survival | 63.9% | 64.2% | 53.2% | 76.9% | 63.4% | 58.9% |
1-year acute rejection | 157 (7.9%) | 134 (6.3%) | 38 (10.6%) | 8 (2.4%) | 69 (6.5%) | 200 (6.6%) |